Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of THB 4.72 trillion. The enterprise value is 6.23 trillion.

Market Cap	4.72T
Enterprise Value	6.23T

Important Dates

The next estimated earnings date is Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Nov 7, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.18%
Shares Change (QoQ)	+0.14%
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	66.51%
Float	5.68B

Valuation Ratios

The trailing PE ratio is 14.91 and the forward PE ratio is 8.75.

PE Ratio	14.91
Forward PE	8.75
PS Ratio	2.33
PB Ratio	1.57
P/TBV Ratio	n/a
P/FCF Ratio	14.12
P/OCF Ratio	11.20
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.62, with an EV/FCF ratio of 18.63.

EV / Earnings	19.67
EV / Sales	3.11
EV / EBITDA	7.62
EV / EBIT	10.98
EV / FCF	18.63

Financial Position

The company has a current ratio of 1.28, with a Debt / Equity ratio of 0.67.

Current Ratio	1.28
Quick Ratio	0.90
Debt / Equity	0.67
Debt / EBITDA	2.42
Debt / FCF	5.97
Interest Coverage	6.59

Financial Efficiency

Return on equity (ROE) is 10.60% and return on invested capital (ROIC) is 7.04%.

Return on Equity (ROE)	10.60%
Return on Assets (ROA)	5.19%
Return on Invested Capital (ROIC)	7.04%
Return on Capital Employed (ROCE)	10.33%
Revenue Per Employee	24.96M
Profits Per Employee	3.91M
Employee Count	81,000
Asset Turnover	0.29
Inventory Turnover	1.36

Taxes

Income Tax	-22.06B
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	16.29
200-Day Moving Average	n/a
Relative Strength Index (RSI)	53.56
Average Volume (20 Days)	233,480

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.93

Income Statement

In the last 12 months, Pfizer had revenue of THB 2.02 trillion and earned 316.54 billion in profits. Earnings per share was 55.59.

Revenue	2.02T
Gross Profit	1.51T
Operating Income	572.51B
Pretax Income	294.77B
Net Income	316.54B
EBITDA	787.70B
EBIT	572.51B
Earnings Per Share (EPS)	55.59

Full Income Statement

Balance Sheet

The company has 482.62 billion in cash and 1.99 trillion in debt, giving a net cash position of -1,512.09 billion.

Cash & Cash Equivalents	482.62B
Total Debt	1.99T
Net Cash	-1,512.09B
Net Cash Per Share	n/a
Equity (Book Value)	3.00T
Book Value Per Share	525.62
Working Capital	332.61B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 421.14 billion and capital expenditures -86.99 billion, giving a free cash flow of 334.16 billion.

Operating Cash Flow	421.14B
Capital Expenditures	-86.99B
Free Cash Flow	334.16B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 74.81%, with operating and profit margins of 28.31% and 15.66%.

Gross Margin	74.81%
Operating Margin	28.31%
Pretax Margin	14.58%
Profit Margin	15.66%
EBITDA Margin	38.96%
EBIT Margin	28.31%
FCF Margin	16.53%

Dividends & Yields

This stock pays an annual dividend of 0.47, which amounts to a dividend yield of 2.89%.

Dividend Per Share	0.47
Dividend Yield	2.89%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	98.75%
Buyback Yield	-0.18%
Shareholder Yield	2.71%
Earnings Yield	6.71%
FCF Yield	7.08%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pfizer has an Altman Z-Score of 2.2 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.2
Piotroski F-Score	7